Deep Health AI India (DDIL): Company Update

Company Update Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed herewith the Statement of Deviation and variation for the Quarter and year ended March 31, 2026, and the detailed statement in relation to the same is enclosed as 'Annexure A'. Further, this is to inform you that the Rights Issue proceeds have been fully utilized during the quarter ended on March 31, 2026. Therefore, the filing of statement of de

1 min read Deep Health AI India

Company Update

Company Update

Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed herewith the Statement of Deviation and variation for the Quarter and year ended March 31, 2026, and the detailed statement in relation to the same is enclosed as 'Annexure A'. Further, this is to inform you that the Rights Issue proceeds have been fully utilized during the quarter ended on March 31, 2026. Therefore, the filing of statement of deviation(s) or variation(s) under the Regulation 32 SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 will not be applicable to the company from here onwards. A statement of deviation or variation for the Quarter and Year ended on March 31, 2026, is duly reviewed by the Audit Committee of the Company at its Meeting held today i.e. on May 29, 2026, and Utilisation Certificate issued by the Statutory Auditor, M/s VRSK & Co. LLP, Chartered Accountants. is enclosed herewith

Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed herewith the Statement of Deviation and variation for the Quarter and year ended March 31, 2026, and the detailed statement in relation to the same is enclosed as 'Annexure A'. Further, this is to inform you that the Rights Issue proceeds have been fully utilized during the quarter ended on March 31, 2026. Therefore, the filing of statement of deviation(s) or variation(s) under the Regulation 32 SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 will not be applicable to the company from here onwards. A statement of deviation or variation for the Quarter and Year ended on March 31, 2026, is duly reviewed by the Audit Committee of the Company at its Meeting held today i.e. on May 29, 2026, and Utilisation Certificate issued by the Statutory Auditor, M/s VRSK & Co. LLP, Chartered Accountants. is enclosed herewith

Disclaimer

This article is for informational purposes only and is not investment advice. Verify all figures and announcements from official exchange filings and company disclosures before making decisions.

#Deep Health AI India Ltd #DDIL #Corporate announcement
Plans built for every investor
TRUSTED BY INVESTORS

Track Indian stocks with ZTOX AI

NSE & BSE filings, quarterly results, insider trades, and smart volume alerts — delivered on WhatsApp or Telegram. No separate app to install.

RK
VJ
SM

"ZTOX alerts helped me catch a multi-bagger stock last quarter. The insider deals notifications are absolutely game-changing for retail investors."

Rahul K., Active Trader
MOST POPULAR
Basic Plan
For active market participants
₹89/mo
Includes:
Track 20 Companies
Insider deals alert
High volume alerts
Start Free
Advanced Plan
For serious investors & traders
₹119/mo
Includes:
Track 50 Companies
All Basic plan features
Block & Preferential Deals
Start Free

No credit card required. Connect WhatsApp or Telegram in minutes.

Secure connection. Your data is always protected.